Results 121 to 130 of about 277,913 (269)
Correction: Development and testing of a composite index to monitor the continuum of maternal health service delivery at provincial and district level in South Africa. [PDF]
Mothupi MC +3 more
europepmc +1 more source
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Coverings and dimensions in infinite profinite groups
Maga Peter
doaj +1 more source
Beyond Single Structures: The Role of Structural Ensembles in Discrete-Continuum Modeling of Highly Charged Metal Ions. [PDF]
Hanson B, Li P.
europepmc +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Stronger Minds, Better Lives: Exercise Self-Efficacy and Resilience as Serial Mediators in Oncology Nurses. [PDF]
Oyur Çelik G +9 more
europepmc +1 more source
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
Contextual F0 cues can outweigh talker F0 cues in fricative perception. [PDF]
Uluşahin O +3 more
europepmc +1 more source
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
Lung cancer screening care pathways in community settings: an examination of 3 healthcare systems. [PDF]
Walsh C +13 more
europepmc +1 more source

